While this should by no means be taken as direct clinical evidence that CBD for weight loss is a tried-and-true remedy for obesity, the studies mentioned above should certainly warrant more investigation into the topic. And to be sure, many folks are already using CBD products to help control their appetite and lose weight. Do a little research online for customer feedback and reviews, and you’ll see what we mean.
Frankel puts his hand on his heart. “Imagine the pressure!” he says. A  complex soul, whose parents survived the Holocaust, Frankel says that  when his patients don’t get better, he’s sad and disappointed, and  starts to question if he’s wasting people’s time and money. “But then  ten people will get better, and I feel… grateful. It makes me confident  I’m on the right road, on the right side of history.” 

Frankel had rarely tried cannabis until he was 49. He was a partner in one of the most successful practices in West Los Angeles and a clinical professor at UCLA Medical School. He’d been my family’s internist for 15 years, and I found him a skilled diagnostician, who listened carefully, and who cared. He had to quit practicing in 2000, after he’d suffered a disabling back injury, then developed a viral infection of the heart and was told he had six months to live. Some of his cancer and AIDS patients urged him to try cannabis. “They did a reverse intervention,” he said, and a year later, his heart was normal. He can’t be certain how or if cannabis healed his heart. “I’d been depressed and CBD stopped the depression,” he said. “It gave me something to look forward to. My brain was turned on.”
Frankel had rarely tried cannabis until he was 49. He was a partner in one of the most successful practices in West Los Angeles and a clinical professor at UCLA Medical School. He’d been my family’s internist for 15 years, and I found him a skilled diagnostician, who listened carefully, and who cared. He had to quit practicing in 2000, after he’d suffered a disabling back injury, then developed a viral infection of the heart and was told he had six months to live. Some of his cancer and AIDS patients urged him to try cannabis. “They did a reverse intervention,” he said, and a year later, his heart was normal. He can’t be certain how or if cannabis healed his heart. “I’d been depressed and CBD stopped the depression,” he said. “It gave me something to look forward to. My brain was turned on.”
He did exhaustive research. He found there’d been decades of scientific studies on the effects of THC and CBD on cells and animals, but few trials with humans, because the FDA classifies cannabis and all its components as Schedule 1 drugs, which have “no accepted medical treatment use.” It took Sue Sisley, an Arizona physician, seven years of struggling with bureaucratic hurdles before she received the first FDA approval for a study, just beginning, of marijuana with vets who have PTSD.
Frankel had rarely tried cannabis until he was 49. He was a partner in one of the most successful practices in West Los Angeles and a clinical professor at UCLA Medical School. He’d been my family’s internist for 15 years, and I found him a skilled diagnostician, who listened carefully, and who cared. He had to quit practicing in 2000, after he’d suffered a disabling back injury, then developed a viral infection of the heart and was told he had six months to live. Some of his cancer and AIDS patients urged him to try cannabis. “They did a reverse intervention,” he said, and a year later, his heart was normal. He can’t be certain how or if cannabis healed his heart. “I’d been depressed and CBD stopped the depression,” he said. “It gave me something to look forward to. My brain was turned on.”

Utah company Kanibi is a new player on the CBD scene. They bring scientific precision and a focus on performance to their products. The company offers a pretty limited product selection: an oil tincture and a sports cream. But they lack in variety, they make up for in quality. Every product gets double lab tested, so consumers know exactly how much CBD they’re getting from their purchase.

Can CBD curb your appetite? Quash anxiety? Protect your heart and brain? Anecdotal evidence for these and other health benefits has created a surge, a potential tsunami of demand for CBD products. While the FDA recently declared CBD an illegal, Schedule 1 drug, it’s being sold in states where medical cannabis is legal, and some companies are shipping it across state lines.
Another study published in 2012 by Farrimond et al. examining the effects of different phytocannabinoids, such as cannabinol (CBN) and CBD, on feeding patterns in rats supports the theory that different cannabinoids modulate CB1 receptors and enhance appetite and metabolism with opposing effects. This study demonstrated that cannabinol increased food intake and body weight gain, while CBD decreased food consumption and weight gain. If your guess is that in this study CBD was also working by “tanning” WAT to BAT, then you are likely spot on.
Moreover, Murray Mittleman, an associate professor of medicine at Harvard Medical School, explained to Time Magazine in 2013 that weed users had lower fasting insulin levels and were less resistant to insulin produced by the body. He was referring to research from the National Health and Nutrition Examination Survey, which analyzed 4,600 men and women over a five year period from 2005 to 2010. 48% of them used cannabis at least once in their lives, and 12% were current users.
Recent evidence from animal and human studies shows a role for the endocannabinoid system in maintaining energy balance and glucose as well as lipoprotein metabolism, according to a 2009 study. Modulation of this system has resulted in an improvement in a number of important risk factors in clinical trials, including visceral and subcutaneous abdominal adipose tissue, glucose tolerance, dyslipidemia and measures of inflammation.
Frankel runs GreenBridge Medical, which he founded in 2006, like an internist’s office. He begins with a one-hour consult, comes up with a treatment plan, and recommends products for which he designed the formulas: ten oils with different combinations of THC and CBD. (THC gets you high; CBD doesn’t, but is alleged to have strong healing properties) The #1 oil is almost all CBD, #10 is almost all THC, and #5 has equal amounts of both. So the doctor, patient, and dispensary know how many milligrams of what chemicals the patient is taking, and the doctor can adjust the dose as needed.

Jennifer Kurtz studied medicine at the New Jersey School of Medicine (Rutgers). She is passionate about developing her knowledge of Cannabis, Nootropics, Kratom, and nutritional supplements. In addition to attending medical webinars and conferences, she loves to write research-based articles for magazines, healthcare professionals, and medical agencies.
Due to the uniqueness of everyone’s endocannabinoid system, CBD does not affect any two people the same way. There are a host of factors that influence its efficacy, including genetics, previous history of use, general health, weight, ethnicity and so on. Therefore, while one person may find that 15 mg of CBD a day works wonders for suppressing appetite and boosting weight loss, another may require up to 100 mg (or more) in order to achieve the same results (or they may not experience any results at all).
You’ve most likely heard of CBD. It is becoming an increasingly popular choice for an array of health complaints and conditions. It is one of 104 cannabinoids, which are specific chemical compounds found in the Cannabis sativa plant. Unlike its sister cannabinoid, THC, CBD provides all the benefits of Cannabis without the psychoactive effects. In other words, it won’t make you high. While many full-spectrum CBD oils contain trace amounts of THC, the amount is negligible and has no noticeable effects.

Recent evidence from animal and human studies shows a role for the endocannabinoid system in maintaining energy balance and glucose as well as lipoprotein metabolism, according to a 2009 study. Modulation of this system has resulted in an improvement in a number of important risk factors in clinical trials, including visceral and subcutaneous abdominal adipose tissue, glucose tolerance, dyslipidemia and measures of inflammation.
CBD and other cannabinoids attach to specific receptors in the body found within what is referred to as the endocannabinoid system. In fact, up until recently, scientists didn’t know that these cannabinoids are actually naturally produced in humans and most animals. Some researchers speculate that an endocannabinoid deficiency may be the cause of many disorders and conditions. When CBD is introduced into the body, it binds to receptor cells called CB1 and CB2 receptors.
© iDWeeds - Consult your (Cannabis) physician before use. CBD can potentially interact with many pharmaceuticals. iDWeeds is an educational cannabinoid resource driven by its users feedback and scientific research. We do not sell or distribute any CBD/cannabis products. We solely review CBD brands based on third-party lab tests to protect users from CBD frauds. Read our full disclaimer.
×